HRP20191862T1 - Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina - Google Patents
Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina Download PDFInfo
- Publication number
- HRP20191862T1 HRP20191862T1 HRP20191862TT HRP20191862T HRP20191862T1 HR P20191862 T1 HRP20191862 T1 HR P20191862T1 HR P20191862T T HRP20191862T T HR P20191862TT HR P20191862 T HRP20191862 T HR P20191862T HR P20191862 T1 HRP20191862 T1 HR P20191862T1
- Authority
- HR
- Croatia
- Prior art keywords
- disease
- antibiotics
- fragment
- vitro diagnostic
- caused
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/585—Calcitonins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09157886 | 2009-04-14 | ||
| EP10717531.7A EP2419741B1 (en) | 2009-04-14 | 2010-04-14 | Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
| PCT/EP2010/002279 WO2010118855A1 (en) | 2009-04-14 | 2010-04-14 | Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20191862T1 true HRP20191862T1 (hr) | 2019-12-27 |
Family
ID=40886944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20191862TT HRP20191862T1 (hr) | 2009-04-14 | 2010-04-14 | Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9046532B2 (https=) |
| EP (1) | EP2419741B1 (https=) |
| JP (1) | JP5650718B2 (https=) |
| CN (2) | CN102395888B (https=) |
| CY (1) | CY1122202T1 (https=) |
| DK (1) | DK2419741T3 (https=) |
| ES (1) | ES2751105T3 (https=) |
| HK (1) | HK1221766A1 (https=) |
| HR (1) | HRP20191862T1 (https=) |
| HU (1) | HUE046182T2 (https=) |
| LT (1) | LT2419741T (https=) |
| PL (1) | PL2419741T3 (https=) |
| PT (1) | PT2419741T (https=) |
| SI (1) | SI2419741T1 (https=) |
| WO (1) | WO2010118855A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2672561C2 (ru) * | 2012-04-12 | 2018-11-16 | Б.Р.А.Х.М.С Гмбх | Прогнозирование нежелательных явлений у пациентов с предполагаемым диагнозом хронической сердечной недостаточности |
| CN105528511A (zh) * | 2014-10-25 | 2016-04-27 | 潘一琦 | 一种远程诊疗对比式问诊方法及其系统 |
| CN107301319B (zh) * | 2017-06-26 | 2021-02-26 | 济南市儿童医院 | 儿科临床及科研中抗菌药物使用危险评估系统 |
| CN111656189A (zh) * | 2017-12-20 | 2020-09-11 | B.R.A.H.M.S有限公司 | 基于合并症患者的降钙素原的抗生素疗法指导 |
| EP3502706A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
| DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
| ATE395364T1 (de) * | 1999-12-22 | 2008-05-15 | Dade Behring Marburg Gmbh | Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung |
| DE60233949D1 (de) * | 2001-08-20 | 2009-11-19 | Biosite Inc | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon |
| US20050148029A1 (en) | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| DE102005034174A1 (de) * | 2005-07-21 | 2007-02-08 | B.R.A.H.M.S Ag | Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen |
| FR2894675B1 (fr) * | 2005-12-14 | 2008-06-27 | Assist Publ Hopitaux De Paris | Distinction des meningites bacteriennes et virales |
| DE102006046996A1 (de) | 2006-10-01 | 2008-04-03 | Brahms Aktiengesellschaft | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
| CN103123359B (zh) | 2007-08-03 | 2015-07-29 | B.R.A.H.M.S有限公司 | 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用 |
-
2010
- 2010-04-14 HR HRP20191862TT patent/HRP20191862T1/hr unknown
- 2010-04-14 PL PL10717531T patent/PL2419741T3/pl unknown
- 2010-04-14 CN CN201080016849.8A patent/CN102395888B/zh active Active
- 2010-04-14 ES ES10717531T patent/ES2751105T3/es active Active
- 2010-04-14 WO PCT/EP2010/002279 patent/WO2010118855A1/en not_active Ceased
- 2010-04-14 DK DK10717531T patent/DK2419741T3/da active
- 2010-04-14 US US13/264,252 patent/US9046532B2/en active Active
- 2010-04-14 PT PT107175317T patent/PT2419741T/pt unknown
- 2010-04-14 EP EP10717531.7A patent/EP2419741B1/en not_active Revoked
- 2010-04-14 JP JP2012505086A patent/JP5650718B2/ja active Active
- 2010-04-14 CN CN201510626744.9A patent/CN105334330A/zh active Pending
- 2010-04-14 SI SI201031945T patent/SI2419741T1/sl unknown
- 2010-04-14 LT LT10717531T patent/LT2419741T/lt unknown
- 2010-04-14 HU HUE10717531A patent/HUE046182T2/hu unknown
-
2015
- 2015-03-30 US US14/672,801 patent/US9810699B2/en active Active
-
2016
- 2016-08-16 HK HK16109795.0A patent/HK1221766A1/zh unknown
-
2017
- 2017-11-06 US US15/804,282 patent/US20180052179A1/en not_active Abandoned
-
2019
- 2019-10-24 CY CY20191101107T patent/CY1122202T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2419741T (pt) | 2019-11-04 |
| EP2419741A1 (en) | 2012-02-22 |
| CN102395888A (zh) | 2012-03-28 |
| US9810699B2 (en) | 2017-11-07 |
| JP2012523573A (ja) | 2012-10-04 |
| US20150247871A1 (en) | 2015-09-03 |
| CY1122202T1 (el) | 2020-11-25 |
| US20180052179A1 (en) | 2018-02-22 |
| PL2419741T3 (pl) | 2020-01-31 |
| DK2419741T3 (da) | 2019-11-04 |
| EP2419741B1 (en) | 2019-07-31 |
| HK1221766A1 (zh) | 2017-06-09 |
| LT2419741T (lt) | 2019-11-11 |
| SI2419741T1 (sl) | 2019-12-31 |
| CN102395888B (zh) | 2017-05-03 |
| WO2010118855A1 (en) | 2010-10-21 |
| JP5650718B2 (ja) | 2015-01-07 |
| HUE046182T2 (hu) | 2020-02-28 |
| US20120100635A1 (en) | 2012-04-26 |
| ES2751105T3 (es) | 2020-03-30 |
| CN105334330A (zh) | 2016-02-17 |
| US9046532B2 (en) | 2015-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20190224135A1 (en) | Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-infectious disease | |
| CN104755930B (zh) | 用于检测分析物的装置和方法 | |
| CN101568833B (zh) | 使用MR-proADM的糖尿病诊断和风险分级 | |
| US11041867B2 (en) | ProADM and/or histones as markers indicating an adverse event | |
| JP2025019061A (ja) | 術後有害事象の診断または予後 | |
| WO2010038974A3 (ko) | 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트 | |
| HRP20191862T1 (hr) | Procjena rizika u liječenju antibioticima kod pacijenata koji boluju od primarne nezarazne bolesti određivanjem razine prokalcitonina | |
| JP7277465B2 (ja) | プロカルシトニンと中間領域プロアドレノメデュリンを使用したリスク評価と患者管理のためのワークフロー | |
| EP3497450B1 (en) | Histones and/or proadm as markers indicating organ dysfunction | |
| WO2013090811A1 (en) | Biomarkers of pulmonary hypertension | |
| JP2024023615A (ja) | 感染性疾患の症状を有する患者において入院を必要とする病状のリスクを予測するためのｐｒｏ－ａｄｍ | |
| FI3356826T3 (fi) | Gdf-15 melanooman diagnostisena markkerina | |
| JP2023095851A (ja) | 抗生物質治療をモニタリングするためのマーカーとしてのｐｃｔおよびｐｒｏ－ａｄｍ | |
| JP2012523573A5 (https=) | ||
| Vaziri et al. | Effects of end‐stage renal disease and dialysis modalities on blood ammonia level | |
| RU2009146803A (ru) | Способ диагностики деструктивного панкреатита | |
| CN111065927B (zh) | 作为危重患者的治疗监测标记物的pro-adm | |
| Hu et al. | Prognostic value of adrenomedullin and natriuretic peptides in uroseptic patients induced by ureteroscopy | |
| WO2014108397A4 (en) | A method for predicting the risk of getting cancer or diagnosing cancer in a subject | |
| RU2788885C2 (ru) | Прокальцитонин и про-адм в качестве маркеров для мониторинга лечения антибиотиками | |
| TWI808323B (zh) | Lama2, plxdc2及mll4作為檢測和識別糖尿病前期和糖尿病的新型生物標記的方法及用途 | |
| Gafor et al. | Evaluating cardiovascular risk in chronic kidney disease patients: A biomarker approach | |
| US20230093131A1 (en) | Assessing and treating alcohol-associated liver disease | |
| WO2025133235A1 (en) | Adm-gly as marker for early predicting sepsis | |
| Mohammed et al. | Obestatin/Ghrelin Ratio as a New Activity Index in Ulcerative Colitis |